Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function

被引:24
作者
Khan, MA
Akari, H
Kao, S
Aberham, C
Davis, D
Buckler-White, A
Strebel, K
机构
[1] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Viral Biochem Sect, NIH, Bethesda, MD 20892 USA
[3] NCI, HIV Malignancy Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1128/JVI.76.18.9112-9123.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human immunodeficiency virus type 1 (HIV-1) Vif protein is specifically packaged into virus particles through an interaction with viral genomic RNA in which it associates with the viral nucleoprotein complex. We now demonstrate for the first time that virus-associated Vif is subject to proteolytic processing by the viral protease (Pr). Pr-dependent processing of Vif was observed both in vivo and in vitro. In vivo processing of Vif was cell type independent and evident by the appearance of a 7-kDa processing product, which was restricted to cell-free virus preparations. Processing of Vif required an active viral Pr and was sensitive to Pr inhibitors such as ritonavir. The processing site in Vif was characterized both in vivo and in vitro and mapped to Ala(150). Interestingly, the Vif processing site is located in a domain that is highly conserved among HIV-1, HIV-2, and simian immunodeficiency virus Vif isolates. Mutations at or near the processing site did not affect protein stability or packaging efficiency but had dramatic effects on Vif processing. In general, mutations that markedly increased or decreased the sensitivity of Vif to proteolytic processing severely impaired or completely abolished Vif function. In contrast, mutations at the same site that had little or no effect on processing efficiency also did not influence Vif function. None of the mutants affected the ability of the virus to replicate in permissive cell lines. Our data suggest that mutations in Vif that cause a profound change in the sensitivity to Pr-dependent processing also severely impaired Vif function, suggesting that intravirion processing of Vif is important for the production of infectious viruses.
引用
收藏
页码:9112 / 9123
页数:12
相关论文
共 64 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   BIOLOGICAL CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 MUTANTS IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
AKARI, H ;
SAKURAGI, J ;
TAKEBE, Y ;
TOMONAGA, K ;
KAWAMURA, M ;
FUKASAWA, M ;
MIURA, T ;
SHINJO, T ;
HAYAMI, M .
ARCHIVES OF VIROLOGY, 1992, 123 (1-2) :157-167
[3]   Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of Vif for optimal infectivity: functional difference between Vif and Nef [J].
Akari, H ;
Uchiyama, T ;
Fukumori, T ;
Iida, S ;
Koyama, AH ;
Adachi, A .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :2945-2949
[4]   Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production [J].
Baraz, L ;
Friedler, A ;
Blumenzweig, I ;
Nussinuv, O ;
Chen, N ;
Steinitz, M ;
Gilon, C ;
Kotler, M .
FEBS LETTERS, 1998, 441 (03) :419-426
[5]   Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors:: co-encapsidation and interference with viral protease-mediated Gag processing [J].
Bardy, M ;
Gay, B ;
Pébernard, S ;
Chazal, N ;
Courcoul, M ;
Vigne, R ;
Decroly, E ;
Boulanger, P .
JOURNAL OF GENERAL VIROLOGY, 2001, 82 :2719-2733
[6]   TRANSCOMPLEMENTATION OF VIF- HIV-1 MUTANTS IN CEM CELLS SUGGESTS THAT VIF AFFECTS LATE STEPS OF THE VIRAL LIFE-CYCLE [J].
BLANC, D ;
PATIENCE, C ;
SCHULZ, TF ;
WEISS, R ;
SPIRE, B .
VIROLOGY, 1993, 193 (01) :186-192
[7]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF(-) MUTANT PARTICLES FROM RESTRICTIVE CELLS - ROLE OF VIF IN CORRECT PARTICLE ASSEMBLY AND INFECTIVITY [J].
BORMAN, AM ;
QUILLENT, C ;
CHARNEAU, P ;
DAUGUET, C ;
CLAVEL, F .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2058-2067
[8]   Phenotypically Vif(-) human immunodeficiency virus type 1 is produced by chronically infected restrictive cells [J].
Bouyac, M ;
Rey, F ;
Nascimbeni, M ;
Courcoul, M ;
Sire, J ;
Blanc, D ;
Clavel, F ;
Vigne, R ;
Spire, B .
JOURNAL OF VIROLOGY, 1997, 71 (03) :2473-2477
[9]   Human immunodeficiency virus type 1 Vif protein binds to the Pr55(Gag) precursor [J].
Bouyac, M ;
Courcoul, M ;
Bertola, G ;
Baudat, Y ;
Gabuzda, D ;
Blanc, D ;
Chazal, N ;
Boulanger, P ;
Sire, J ;
Vigne, R ;
Spire, B .
JOURNAL OF VIROLOGY, 1997, 71 (12) :9358-9365
[10]   Characterization of human immunodeficiency virus type 1 Vif particle incorporation [J].
Camaur, D ;
Trono, D .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6106-6111